Skip to results
Modify your search
NARROW
1-20 of 25
Authors: Joachim P Steinbach
Journal Article
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l -tyrosine PET
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf023, https://doi.org/10.1093/noajnl/vdaf023
Published: 29 January 2025
Journal Article
CNSC-16. ASSOCIATION BETWEEN RESTING-STATE-NETWORK FUNCTIONAL CONNECTIVITY AND SURVIVAL IN RECURRENT GLIOMAS DIAGNOSED USING FET PET
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii43–viii44, https://doi.org/10.1093/neuonc/noae165.0172
Published: 11 November 2024
Journal Article
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae138, https://doi.org/10.1093/noajnl/vdae138
Published: 02 August 2024
Journal Article
Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2084–2099, https://doi.org/10.1093/neuonc/noae094
Published: 04 June 2024
Includes: Multimedia
Journal Article
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad131, https://doi.org/10.1093/noajnl/vdad131
Published: 17 October 2023
Journal Article
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 2058–2071, https://doi.org/10.1093/neuonc/noad087
Published: 06 May 2023
Journal Article
EDITOR'S CHOICE
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Neuro-Oncology, Volume 22, Issue 8, August 2020, Pages 1162–1172, https://doi.org/10.1093/neuonc/noaa033
Published: 17 February 2020
Journal Article
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Neuro-Oncology, Volume 20, Issue 7, July 2018, Pages 975–985, https://doi.org/10.1093/neuonc/nox204
Published: 07 November 2017
Journal Article
EDITOR'S CHOICE
Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death
in
Brain
Brain, Volume 140, Issue 10, October 2017, Pages 2623–2638, https://doi.org/10.1093/brain/awx196
Published: 11 August 2017
Journal Article
To diet or not to diet – that is still the question
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1035–1036, https://doi.org/10.1093/neuonc/now131
Published: 05 July 2016
Journal Article
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1146–1156, https://doi.org/10.1093/neuonc/now009
Published: 21 February 2016
Journal Article
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
JNCI: Journal of the National Cancer Institute, Volume 108, Issue 5, May 2016, djv375, https://doi.org/10.1093/jnci/djv375
Published: 06 December 2015
Journal Article
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas
Neuro-Oncology, Volume 18, Issue 2, February 2016, Pages 173–183, https://doi.org/10.1093/neuonc/nov288
Published: 30 November 2015
Journal Article
NIMG-40MRI TUMOR PROGRESSION PATTERNS IN THE GLARIUS TRIAL
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v162–v163, https://doi.org/10.1093/neuonc/nov225.40
Published: 09 November 2015
Journal Article
NIMG-41MRI FINDINGS IN THE GLARIUS TRIAL: PROGNOSTIC AND PREDICTIVE IMPLICATIONS
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v163, https://doi.org/10.1093/neuonc/nov225.41
Published: 09 November 2015
Journal Article
EDITOR'S CHOICE
Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics Get access
Neuro-Oncology, Volume 16, Issue 11, November 2014, Pages 1469–1477, https://doi.org/10.1093/neuonc/nou167
Published: 25 August 2014
Journal Article
ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii44, https://doi.org/10.1093/neuonc/nou209.9
Published: 01 July 2014
Journal Article
MOLECULAR GENETIC DETERMINANTS OF LONG-TERM SURVIVAL WITH GLIOBLASTOMA Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Pages iii46–iii47, https://doi.org/10.1093/neuonc/nou209.19
Published: 01 July 2014
Journal Article
Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival Get access
Neuro-Oncology, Volume 15, Issue 10, October 2013, Pages 1395–1404, https://doi.org/10.1093/neuonc/not105
Published: 07 August 2013
Journal Article
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation Get access
Neuro-Oncology, Volume 15, Issue 10, October 2013, Pages 1405–1412, https://doi.org/10.1093/neuonc/not100
Published: 01 August 2013
